Virtual Research and Development Day to be held on June 14 at 4:30 pm. (Webcast Link):(https://ir.sab.bio/events/event-details/sab-biotherapeutics-2023-annual-rd-day)
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on SABS:
- SAB Biotherapeutics to Present Novel Human IgG Platform with Positive Data and Breakthrough Therapy and Fast-Track Designations for Influenza Treatment at BIO 2023 International Convention
- SAB Biotherapeutics Presents Virtual 2023 R&D Day Portfolio Update: Breakthrough Immunotherapy Innovations
- SAB Biotherapeutics Provides Company Update for Q1 2023 Financial Results
- SAB Biotherapeutics Announces First Publication of Promising Nonclinical Data for SAB-183 Against Pneumonic Plague in the Journal Antibodies
- SAB Biotherapeutics Announces Progress on U.S. FDA’s Phased Review of Company’s Groundbreaking DiversitAb™ Platform